FARALLON CAPITAL MANAGEMENT LLC - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q3 2023$5,105,291
+210.7%
6,130,272
+2929.9%
0.03%
+271.4%
Q2 2021$1,643,000
+26.4%
202,326
+102.3%
0.01%
-30.0%
Q2 2020$1,300,000
+28.1%
100,0000.0%0.01%
+11.1%
Q1 2020$1,015,000
-87.0%
100,000
-80.0%
0.01%
-83.0%
Q4 2019$7,815,000
+362.2%
500,000
+396.5%
0.05%
+307.7%
Q3 2019$1,691,000
-23.8%
100,712
+0.7%
0.01%
-7.1%
Q2 2019$2,218,000
-72.9%
100,000
-73.5%
0.01%
-77.4%
Q1 2019$8,188,000377,8520.06%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,513,138$19,020,0004.68%
Omega Fund Management, LLC 3,320,608$41,740,0004.68%
Ally Bridge Group (NY) LLC 1,175,000$14,770,0004.34%
Parkman Healthcare Partners LLC 786,870$9,891,0002.50%
Palo Alto Investors LP 1,772,950$22,286,0001.34%
HHLR ADVISORS, LTD. 7,420,974$93,282,0001.22%
Ikarian Capital, LLC 1,351,933$16,995,0001.20%
Boxer Capital, LLC 2,462,358$30,952,0001.08%
ACUTA CAPITAL PARTNERS, LLC 215,000$2,703,0000.95%
EMERALD ADVISERS, LLC 1,516,003$19,056,0000.69%
View complete list of GOSSAMER BIO INC shareholders